← All stocks

Pharvaris N.V.

PHVS Net selling

CIK 0001830487 #1865 in the set updated 21 Sep 2026

Bought (120 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$18.56M

$4.26M on a plan · $13.36M straight out of an exercise

Sold at will

$939.22K

4 of 63 sales

Net

−$18.56M

−$939.22K against sales at will

By person

11 insiders · 63 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Lesage Anne

Chief Early Development

—

$5.91M (18) scheduled

−$5.91M

150,419

0.2307%

$5.76M

−31.8%

Lu Peng

President

—

$3.45M (12) scheduled

−$3.45M

64,953

0.0996%

$2.49M

−2.0%

Schikan Johannes Gerardus Christiaan Petrus

Director

—

$2.63M (8) scheduled

−$2.63M

315,167

0.4833%

$12.06M

−20.2%

Abele Stefan Andreas

Chief Technical Ops Officer

—

$2.03M (3) scheduled

−$2.03M

39,068

0.0599%

$1.50M

−20.6%

Souverijns Wim

Chief Commercial Officer

—

$1.32M (3) scheduled

−$1.32M

39,021

0.0598%

$1.49M

−29.2%

Modig Berndt

Chief Executive Officer

—

$1.10M (9) scheduled

−$1.10M

1,078,334

1.65%

$41.27M

−3.3%

Glassman Robert

Director

—

$930.36K (4) scheduled

−$930.36K

10,500

0.0161%

$401.87K

−30.8%

Nijdam Anna

Principal Accounting Officer

—

$307.48K (3) scheduled

−$307.48K

46,275

0.0710%

$1.77M

−10.7%

Nassif David W.

CFO / CLO

—

$303.08K (1)

−$303.08K

120,300

0.1845%

$4.60M

−7.7%

Bjork Elisabeth

Director

—

$293.17K (1) scheduled

−$293.17K

15,167

0.0233%

$580.49K

0.0%

Monges Viviane

Director

—

$292.85K (1)

−$292.85K

5,500

0.0084%

$210.50K

−63.7%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 44

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 19

Sales straight out of an exercise 40

Sales at will 4

Transactions with no price 0

Shares from compensation/vesting 312,337

History held since 3 Apr 2026